# Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)

> **NCT01511887** · NA · COMPLETED · sponsor: **Hormozgan University of Medical Sciences** · enrollment: 40 (actual)

## Conditions studied

- Patent Ductus Arteriosus

## Interventions

- **DRUG:** Oral Ibuprofen

## Key facts

- **NCT ID:** NCT01511887
- **Lead sponsor:** Hormozgan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-12
- **Final completion:** 2012-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511887, "Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01511887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*